https://www.stellarmr.com/report/Daptomycin-Market/2065 Daptomycin is the first new natural-product antibiotic launched in a generation. It was licensed first for skin and soft tissue infections (SSTIs) and, more recently, for staphylococcal bacteraemia and endocarditis. Antibiotics are used to treat bacterial infections. They act by either killing germs or preventing microbial growth.